AnnouncementsShasun Pharma approves amalgamation with Strides Arcolab
AnnouncementsShasun Pharmaceuticals: Outcome of AGM
100% of moneycontrol users recommend buying Shasun Pharma.
What's your call on Shasun Pharma today?
Read 2 investor views
|Company Name||Last Price||%
|Dr Reddys Labs||3538.60||-0.79||3581.70||2250.00||60,285.66|
|Sep' 14||Jun' 14||May' 14||Mar' 14|
DCB Bank Recommended on Aug 19th 2014
Recommended price 81.00 | Peak from reco 107.05 31.51%
What are Multi baggers?
Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.
Shasun Pharma is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 1,310.70 crore.The company has reported a consolidated sales of Rs 306.03 crore and a Net Profit of Rs 1.30 crore for the quarter ended Sep 2014.
The company management includes R Kannan - Chairman, S Abhaya Kumar - Managing Director, Suuny Sharma - Non Executive Director, S Devendra - Whole Time Director, S Vimal Kumar - Whole Time Director, R Sundara Rajan - Independent Director, N Subramanian - Independent Director, Indira J Parikh - Independent Director, Arun Chandra Karmakar - Director.
It is listed on the BSE with a BSE Code of 524552 and the NSE with an NSE Code of SHASUNPHAR.
Its Registered office is at Batra Centre, 3rd & 4th Floor 28,,,Sardar Patel Road, Chennai (Madras),Tamil Nadu - 600032.
Their Registrars are Integrated Enterprises (India) Ltd.